Core Viewpoint - The Hong Kong stock market is experiencing a surge in IPO activity, with multiple companies set to list in the coming days, indicating a robust market environment for new listings [1][3][18]. Group 1: Upcoming IPOs - On June 30, six companies announced their IPOs, with plans to list between June 30 and July 4, 2025 [1][3]. - The companies planning to list include Lens Technology, Fortior, Xunzhong Communication, Jizhi Jia, Dazhong Oral, and Shougang Longze, with Lens Technology and Fortior being A-share listed companies [1][3]. - Three companies, including Taide Pharmaceutical, Yunzhisheng, and IFBH, successfully listed on June 30, 2025, with Taide Pharmaceutical's share price set at 30.6 HKD [1][4]. Group 2: Financial Performance of Listed Companies - Yunzhisheng reported revenues of approximately 601 million RMB, 727 million RMB, and 939 million RMB for 2022, 2023, and 2024, respectively, with net losses of 375 million RMB, 376 million RMB, and 454 million RMB [4][6]. - Taide Pharmaceutical raised approximately 514 million HKD, with a net amount of about 429 million HKD after expenses, and secured two cornerstone investors contributing a total of 10 million USD [8]. - IFBH raised around 1.158 billion HKD, with a net amount of approximately 1.074 billion HKD, and is recognized as the second-largest coconut water beverage company globally [8]. Group 3: Market Trends and Future Outlook - The Hong Kong stock exchange has seen over 40 new listings in the first half of 2025, a significant increase compared to the same period in 2024, with total fundraising exceeding 100 billion HKD [17]. - The market is expected to remain active, with more companies preparing for IPOs, including those that have already submitted applications [17][18]. - The trend indicates a growing interest from A-share listed companies to enter the Hong Kong market, with over 70 companies submitting applications in June 2025 alone [17].

极智嘉提供了一系列AMR解决方案，旨在赋能仓储履约和工业搬运场景，在大幅提高供应链效率的同 时减少对人工的依赖。于2024年，公司终端客户复购率达74.6%。 产品订单量的快速增长拉动了极智嘉收入的提升，其收入由2022年的14.52亿元(单位人民币，下同)增长 至2024年的24.09亿元。 然而，由于销售成本及多项开支高企以及面临赎回负债账面值变动，极智嘉陷入了亏损旋涡，过去三年 的年内亏损分别为15.67亿元、11.27亿元及8.32亿元，三年累计亏损35.25亿元。 财华社讯，6月30日，极智嘉-W（02590.HK）启动招股，计划全球发售约1.4亿股H股，其中约1.26亿股 股份为国际发售股份，1403.54万股股份为香港公开发售股份。 此次港股IPO，极智嘉引入雄安机器人、亿格、Eastspring Investments及Arc Avenue作为基石投资者，基 石投资者合计认购约9130万美元的发售股份。基于发售价16.80港元，基石投资者将认购的发售股份总 数将为4266.22万股发售股份，约占紧随全球发售完成及发售量调整权和超额配股权获悉数行使后公司 已发行股本总额的3.28%。 在港股IP ...

Group 1 - The company plans to globally offer 140 million shares, with 14.0354 million shares available in Hong Kong and 126 million shares for international sale, along with an over-allotment option of 21.0528 million shares [1] - The subscription period for the shares is from June 30 to July 4, with a maximum offer price of HKD 16.80 per share and an entry fee of approximately HKD 3,393.89 for 200 shares [1] - The total expected fundraising amount is HKD 2.358 billion, with a net amount of HKD 2.206 billion, which will be allocated for R&D investments, enhancing international brand influence, developing a digital management platform, upgrading cybersecurity IT infrastructure, and supporting supply chain development [1] Group 2 - The company holds a leading position in the global Autonomous Mobile Robot (AMR) market, providing a range of AMR solutions aimed at enhancing warehouse fulfillment and industrial handling while reducing reliance on manual labor [2] - The company's net profits for the fiscal years ending December 31 are projected to be -1.567 billion in 2022, -1.127 billion in 2023, and -0.832 billion in 2024, reflecting year-on-year changes of -49.22%, 28.10%, and 26.20% respectively [2]